ALLMedicine™ Lipid Disorders Center
Research & Reviews 246 results
Journal of Clinical Hypertension (Greenwich, Conn.); Miao CY, Ye XF et. al.
Jun 7th, 2021 - Dyslipidemia is an emerging disease in China, especially in the presence of hypertension and diabetes mellitus. We investigated the association of dyslipidemia with the use of antihypertensive and antidiabetic agents. The study participants (n = 2...
Pediatric Annals; Leopold S, Zachariah JP
May 27th, 2021 - Current scientific evidence has proven that atherosclerosis is a process that begins in childhood and tracks into adulthood, likely culminating in adverse cardiovascular events such as coronary artery disease, peripheral artery disease, and stroke...
Food & Function; Wang R, Liu S et. al.
Apr 24th, 2021 - Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. leaves (ESL) were reported to have neuroprotective function and are also used to treat cranial and cerebral traumas as a traditional Chinese medicine and food herbage plant. However, there has bee...
Lipids in Health and Disease; Lee ZV, Llanes EJ et. al.
Apr 17th, 2021 - Cardiovascular disease (CVD) is a major cause of mortality and morbidity within the Asia-Pacific region, with the prevalence of CVD risk factors such as plasma lipid disorders increasing in many Asian countries. As members of the Cardiovascular RI...
Endocrine Journal; Zhang J, Ji X et. al.
Mar 19th, 2021 - Fenofibrate is a marketed fibric acid derivative for lipid-lowering in patients with lipid disorders. Numerous studies have proven fenofibrate had a certain effect on serum uric acid, here we conducted this study to quantitatively assess the effec...
Guidelines 2 results
American Family Physician;
Jan 12th, 2017 - Screening for Lipid Disorders in Children and Adolescents: Recommendation Statement.|2017||therapeutic use,diagnosis,therapy,diagnosis,drug therapy,
JAMA , Bibbins-Domingo K et. al.
Nov 14th, 2016 - Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States, accounting for 1 of every 3 deaths among adults. To update the 2008 US Preventive Services Task Force (USPSTF) recommendation on screening for lipid...
Drugs 1 results see all →
Clinicaltrials.gov 10 results
Apr 2nd, 2019 - The AF Survey is a cross-sectional observational study aimed to assess the prevalence and control of AF and its correlation with CVD risk factors in Poland, based on a representative sample of adults aged 65+. The main aim of the survey is to asse...
Oct 16th, 2018 - Insulin resistance has been implicated as the central mechanism in the development of several cardiovascular risk factors including hypertension, diabetes, lipid disorders, and coagulation disorders. Recent evidence suggests that increased levels ...
Aug 31st, 2018 - The primary purpose of this discovery protocol is to identify new lipid genes from subjects with rare genetic lipids disorders. We will take advantage of the new technology of whole exome sequencing to find the cause of dyslipidemia that we haven ...
Sep 11th, 2017 - Chronic kidney disease[CKD] is becoming a serious health problem.The number of people with impaired renal function is rapidly rising, especially in industrialized countries. It is increasing rapidly worldwide at an annual growth rate of 8%. Chroni...
Jan 27th, 2014 - Children with high cholesterol levels are especially vulnerable and are at high risk for early onset coronary heart disease (CHD). Endothelial dysfunction, the earliest phase of CHD, is present in children with elevated cholesterol levels as early...
News 43 results
Feb 10th, 2021 - People with diabetes pose a particular challenge when trying to assess cognitive function longitudinally. Population data suggest that the risk of developing dementia, both vascular and neurodegenerative, among people with diabetes followed for 20...
Jun 13th, 2020 - Semglee, a long-acting human insulin analogue, has been approved for glycemic control in adults and children with type 1 diabetes and adults with type 2 diabetes, the Food and Drug Administration announced June 11. "Long-acting insulin products li...
Richard Franki, MDedge News
Mar 2nd, 2018 - Heart failure, with 42 medicines currently in development, is the leading area for new treatments of cardiovascular disease, according to Pharmaceutical Research and Manufacturers of America. One of those 42 treatments is “a nonviral gene therapy.
Zareen Farukhi, MD, Samia Mora, MD, MHS
Dec 1st, 2017 - Yes. The time has come to change the way we think about fasting before routine lipid testing.
Sep 29th, 2017 - Common over-the-counter doses of biotin supplements -- popular for hair growth, lipid disorders, and other presumptive benefits -- interfere with assays for N-terminal pro-brain natriuretic peptide (NT-proBNP) and other common analytes in blood, r...